ANI: US FDA approves expanded label for ANI Pharma's Iluvien to treat chronic noninfectious uveitis affecting the posterior segment of the eye
ANI Pharmaceuticals, Inc., a diversified biopharmaceutical company, announced that the US Food and Drug Administration (FDA) has approved
Read full article »
ANI is a Minnesota-based pharmaceutical company that develops and commercializes generic prescription medicines for the treatment of various diseases.
Read more